Tinea Capitis: Diagnosis and Management

Overview

Epidemiology and Causative Organisms

• United States/UK: T. tonsurans accounts for >90% of cases; has a predilection for individuals with Afro-textured hair. African American and Latino children are disproportionately affected.
• Europe: M. canis historically dominant, but T. tonsurans has emerged as a major agent reflecting immigration patterns. T. violaceum incidence is also rising in western/Mediterranean Europe.
• Asia: T. violaceum and M. ferrugineum predominate in East Asia.
• Africa: T. soudanense, T. violaceum, T. schoenleinii, and Microsporum spp. drive large-scale epidemics.
• Pets: M. canis (cats/dogs) is the main zoonotic cause worldwide.

2024-2025 update: T. violaceum infections are increasingly reported in the US and Europe, likely due to immigration. Antifungal-resistant strains are an emerging concern - particularly in Europe, with resistance to terbinafine and even voriconazole being described. Antifungal stewardship is now emphasized. (Hill et al., J Fungi 2024, PMID: 38786712)

Patterns of Hair Invasion

Fig. Three patterns of hair invasion - Dermatology: 2-Volume Set 5e

Clinical Presentations

1. Non-inflammatory / Seborrheic Type

2. Gray Patch Tinea Capitis

3. Black Dot Tinea Capitis

Fig. Tinea capitis (black dot pattern) - Andrews' Diseases of the Skin

4. Kerion Celsii (Inflammatory Type)

Fig. Kerion - Andrews' Diseases of the Skin

5. Favus

Diagnosis

Clinical Diagnosis

1. Wood's Lamp (UV 365 nm)

• Positive (yellow-green fluorescence): M. canis, M. audouinii, M. ferrugineum, M. distortum (ectothrix organisms)
• Positive (blue-white): T. schoenleinii (favus)
• Negative: T. tonsurans, T. violaceum (most common US/UK organisms) - do NOT fluoresce
• Dandruff fluoresces bright blue-white; infected hair fluoresces yellow-green due to pteridine

2025 update: Wood's lamp is most useful for M. canis in children, with recent studies confirming its role in early detection. Since T. tonsurans does not fluoresce, a negative Wood's lamp does NOT rule out tinea capitis.

2. KOH (Potassium Hydroxide) Preparation

• Sensitivity: 59-73%
• Collect broken hairs (black dots) or scalp scrapings
• Endothrix: chains of large spores inside the hair shaft
• Ectothrix: spores outside the hair shaft, cuticle destruction

3. Fungal Culture (Gold Standard)

• Sensitivity: 51-97% (higher than KOH)
• Method: Moisten a cotton swab or toothbrush with tap water and rub over scalp lesion, then inoculate Sabouraud dextrose agar or dermatophyte test medium (DTM)
• Results in 1-4 weeks
• High false-negative rate in kerion due to inflammatory immune response destroying hyphae
• Important for species identification (affects drug choice)

4. Dermoscopy / Trichoscopy

• Increasingly used as a non-invasive adjunct
• Characteristic findings: "comma hairs," "corkscrew hairs," "morse code hairs," and dystrophic broken hairs are pathognomonic for tinea capitis
• Highly useful for distinguishing from alopecia areata (which shows exclamation mark hairs, yellow dots)

5. PCR Testing

• Emerging modality; faster than culture
• Especially useful for identifying species and detecting resistance mutations
• Now included in updated guidelines as a confirmatory test option (PMC12707599, 2025)

6. Histopathology (Periodic Acid-Schiff / PAS Stain)

• Shows arthroconidia and hyphae within the hair shaft to the level of Adamson's fringe
• Used when other tests are inconclusive

Differential Diagnosis

Key pitfall: Before draining a scalp abscess in a child, always consider kerion and send fungal culture. - Andrews' Diseases of the Skin

Management

Principle: Always Use Systemic (Oral) Antifungals

First-Line Systemic Agents

Terbinafine (Preferred for Trichophyton spp.)

• Mechanism: Allylamine - inhibits squalene epoxidase, accumulates in keratin
• Children:
  • <20 kg: 62.5 mg/day
  • 20-40 kg: 125 mg/day

  • 40 kg: 250 mg/day

• Adults: 250 mg/day
• Duration:
  • T. tonsurans: 2-6 weeks
  • M. canis: 8-12 weeks (terbinafine less effective for Microsporum)
• Evidence: A Cochrane review of RCTs confirms terbinafine is equally effective to griseofulvin with shorter treatment courses. (Grade A, PMC12707599)
• Note: Terbinafine granules can be mixed with food (for younger children). Crushed generic tablets are an off-label alternative if granules are unavailable.

Griseofulvin (Preferred for Microsporum spp.)

• Mechanism: Fungistatic; binds microtubules and disrupts mitosis; concentrates in keratin
• Dose: Microsize: 20-25 mg/kg/day (max 1g/day); Ultramicrosize: 10-15 mg/kg/day
• Duration: 6-8 weeks (longer than terbinafine)
• Take with fatty meal to enhance absorption
• FDA approved for tinea capitis in children >2 years
• Superior to terbinafine for M. canis infections
• 2024 update: Griseofulvin availability has become limited in some countries, raising questions about alternative first-line agents. (Bonifaz et al., Expert Rev Anti Infect Ther 2024, PMID: 39297581)

Alternative Systemic Agents

Adjunctive Topical Therapy (Reduces Transmission)

• Selenium sulfide 2.5% shampoo or ketoconazole 2% shampoo or ciclopirox 1.5% shampoo
• Use every other day or twice weekly for the first 2 weeks of oral therapy
• Reduces spore shedding and transmission to household contacts
• Household/close contacts should also use sporicidal shampoo for 2-4 weeks

Management of Kerion

1. Start oral antifungal immediately - do not wait for culture results
2. Consider short course of oral corticosteroids (e.g., prednisolone 1 mg/kg/day for 1-2 weeks) alongside antifungals to reduce inflammation and risk of scarring alopecia
3. Do not incise and drain - this is not a bacterial abscess
4. Antibacterials are NOT routinely required (secondary bacterial infection is uncommon)
5. Hair typically regrows after adequate treatment, but delay risks permanent scarring

Management of Asymptomatic Carriers

• 5-15% of urban children in Western countries have positive scalp cultures but no symptoms
• In one study, 60% of African American children with positive cultures were asymptomatic
• Asymptomatic contacts: No KOH/culture needed but consider empiric sporicidal shampoo for 2-4 weeks

Infection Control and Prevention

• Children may return to school after starting oral therapy (no need to miss school)
• For the first 14 days: avoid sharing combs, brushes, hats, helmets, or pillowcases
• Avoid head-to-head contact sports (wrestling) for 14 days
• Discard or disinfect combs, brushes, and headwear used by the patient
• Screen all household members clinically (but not necessarily with cultures)
• Antifungal shampoo for all household contacts until patient is cured

Follow-Up

• Clinical reassessment at end of treatment course
• Routine follow-up cultures are not needed if there is clear clinical improvement
• If no improvement: check adherence, consider culture for species ID and resistance testing

Special Populations

Adults with Tinea Capitis

• Postmenopausal women and immunocompromised adults are most affected
• No widely accepted separate adult guidelines exist; same drugs used as in children at adult doses
• Risk factors: crowded living, animal exposure, immunosuppression, household contact with infected child
• Delayed diagnosis is common in adults, raising risk of scarring alopecia (Hill et al., J Fungi 2024 - PMID: 38786712)

Immunocompromised Patients

• May require longer courses or higher doses
• Species identification and susceptibility testing are especially important
• Consider itraconazole or fluconazole as alternatives

Summary: Drug-Species Matching Guide

2024-2025 Key Updates

1. Terbinafine is now the preferred first-line agent for Trichophyton species - Cochrane evidence (Grade A) confirms equivalence to griseofulvin with shorter courses. (PMC12707599, 2025)
2. PCR testing is now listed alongside KOH and culture as a diagnostic option in updated guidelines.
3. Griseofulvin supply issues in some countries are reshaping first-line therapy decisions, with itraconazole and fluconazole positioned as alternatives (PMID: 39297581).
4. Emerging antifungal resistance - particularly among T. violaceum and related species in Europe - requires antifungal stewardship; avoid combination antifungal-corticosteroid products as they promote resistance (PMC12707599).
5. Adults with tinea capitis (especially postmenopausal Black women) are a neglected and under-recognized population; screening awareness needs to improve (PMID: 38786712).
6. Wood's lamp with LED technology is being re-evaluated for M. canis detection in children (Sun et al., Photodiagnosis Photodyn Ther 2025).

• Dermatology: 2-Volume Set 5e (Elsevier), p. 1609
• Andrews' Diseases of the Skin 13e, p. 344
• Fitzpatrick's Dermatology 9e, Vol. 1-2
• Goodman & Gilman's Pharmacological Basis of Therapeutics
• Harriet Lane Handbook 23e (terbinafine dosing)
• PMC12707599 - "Diagnosis and Management of Tinea Infections," updated AAFP guidelines (2025)
• Hill RC et al., J Fungi 2024, PMID: 38786712 - Comprehensive review of tinea capitis in adults
• Bonifaz A et al., Expert Rev Anti Infect Ther 2024, PMID: 39297581 - Griseofulvin availability crisis